Saltar al contenido
MilliporeSigma
Todas las fotos(2)

Documentos clave

Ver Toda la documentación

GHS316

Sigma-Aldrich

Hematoxylin Solution, Gill No. 3

Iniciar sesiónpara Ver la Fijación de precios por contrato y de la organización
Todas las fotos(2)

About This Item

MDL number:
MFCD00283324
UNSPSC Code:
41116124
NACRES:
NA.47

form

solution

Quality Level

500

shelf life

Expiry date on the label.

IVD

for in vitro diagnostic use

concentration

6 g/L

application(s)

hematology
histology

storage temp.

room temp

¿Está buscando productos similares? Visita Guía de comparación de productos

Categorías relacionadas

Application

Gill formulation No. 3 may be used for cytology and/or histology as a progressive or regressive stain depending on length of staining time.. Used with hematoxylin and eosin staining.

Other Notes

6 g/L certified hematoxylin

pictograms

Health hazardCorrosion
GHS08,GHS05

signalword

Danger

Hazard Classifications

Eye Dam. 1 - Met. Corr. 1 - STOT RE 2 Oral

target_organs

Kidney

Storage Class

8A - Combustible corrosive hazardous materials

wgk_germany

WGK 1

Certificados de análisis (COA)

Busque Certificados de análisis (COA) introduciendo el número de lote del producto. Los números de lote se encuentran en la etiqueta del producto después de las palabras «Lot» o «Batch»

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos

Radhika Rao Arasala et al.
Stem cell research, 37, 101444-101444 (2019-05-11)
Human pluripotent stem cells (hPSCs) acquire changes at the genomic level upon proliferation and differentiation (Peterson and Loring, 2014). Studies from International Stem Cell Initiative and independent laboratories identified a copy number variant (CNV) in hES cell lines displaying a
LaTayia M Aaron-Brooks et al.
The Prostate, 79(9), 980-993 (2019-04-19)
Prostatic inflammation and various proinflammatory systemic comorbidities, such as diabetes and obesity are associated with human benign prostatic hyperplasia (BPH). There is a paucity of in vivo models reflecting specific aspects of BPH pathogenesis. Our aim was to investigate the
Olivia D Lara et al.
Scientific reports, 9(1), 17589-17589 (2019-11-28)
The prognostic and therapeutic value of the tumor microenvironment (TME) in various cancer types is of major interest. Characterization of the TME often relies on a small representative tissue sample. However, the adequacy of such a sample for assessing components
Alejandro Villar-Prados et al.
Molecular cancer therapeutics, 18(2), 421-436 (2018-11-14)
Systematic approaches for accurate repurposing of targeted therapies are needed. We developed and aimed to biologically validate our therapy predicting tool (TPT) for the repurposing of targeted therapies for specific tumor types by testing the role of Bromodomain and Extra-Terminal
Ido Sagi et al.
Cell stem cell, 25(3), 419-432 (2019-09-07)
Genomic imprinting is an epigenetic mechanism that results in parent-of-origin monoallelic expression of specific genes, which precludes uniparental development and underlies various diseases. Here, we explored molecular and developmental aspects of imprinting in humans by generating exclusively paternal human androgenetic

Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.

Póngase en contacto con el Servicio técnico